Skip to main content

Baltimore City-Based Medical Device Startup ReGelTec raises $3.75M in Series A Funding

ReGelTec, a Baltimore City-based medical device startup, has raised $3.75M in Series A funding. The new funding will assist the company in conducting clinical trials in South America for its “HYDRAFIL” hydrogel, a treatment for chronic lower back pain. According to, ReGelTec is overseeing trials remotely via Zoom and 11 patients have undergone the procedure thus far.

Read More

Subscribe to our mailing list: